病:第1型糖尿病的遗忘遗产
Merlin C Thomas1, Sophia Zoungas2,3, Nordin M J Hanssen4
1Department of Diabetes, School of Translational Medicine, Monash University, Melbourne, Australia.
Diabetes care
|June 6, 2025
概括
1型糖尿病加速了功能下降的速度. 新疗法对脏保护有希望,但需要进行临床试验以确保1型糖尿病患者的安全性和有效性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 1型糖尿病 (T1D) 与逐渐下降的功能有关.
- 改善T1D生存率增加了不可逆转的损伤影响结果的风险.
- 目前的治疗方法可以减少严重的白蛋白尿症,但不能减缓脏整体衰退.
研究的目的:
- 审查T1D新兴的脏保护策略.
- 评估辅助疗法的潜力,以改善T1D的脏结果.
- 强调需要在T1D管理中进行根本性的转变,优先考虑脏保护.
主要方法:
- 审查关于脏保护剂的当前文献.
- 对葡萄糖类1受体激动剂,阿尔多抗体和-葡萄糖共运输体2抑制剂的证据分析.
- 讨论非标签使用和T1D临床试验的必要性.
主要成果:
- 新的脏保护剂在患有脏疾病的2型糖尿病中显示出有效性.
- 由于迫切需要,这些药物在T1D中被非标签使用.
- 在T1D中有效性和安全性数据有限,需要进一步的临床研究.
结论:
- 迫切需要基础T1D管理,包括早期脏保护.
- 新兴疗法在T1D中提供了潜在的辅助作用,以保持功能.
- 在临床试验中仔细考虑疗效和安全性在T1D广泛采用之前至关重要.
相关概念视频
Chronic Kidney Disease I: Introduction
78
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
78
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Chronic Kidney Disease III: Interprofessional Care
87
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
87
Kidney Transplant I: Introduction
65
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
65


